Varvara Melikhova

Biomimedica, Inc. develops medical devices to restore damaged joints. Its main focus is to treat degenerative disease of articular cartilage, which is called Osteoarthritis. The company was founded by David Myung and Lampros Kourtis in 2008 and is headquartered in Ripon, CA.

Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.

BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.

Valence Investments SPV IV LLC engages in the provision of biotechnology services. The company is headquartered in New York, NY.

Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA.

Helix Ventures LLC (Helix Ventures) is a venture capital firm founded in 2008 by Graham Crooke, Philip Sawyer and Evgeny Zaytsev. The firm is headquartered in Palo Alto, California.

Sonoma Orthopedic Products, Inc. develops and manufactures orthopedic devices. The company was founded by Stephen D. Guntherand and Charles L. Nelson in 2005 and is headquartered in Buffalo Grove, IL.

Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA.

TPE Boulder, Inc. (Ticonderoga Capital) is a private equity firm founded by James Vandervelden in 1997. The firm is headquartered in Braintree, Massachusetts.

Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA.

Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA.